Ovarian Cancer Innovations Group (OCIG) Research

Ovarian Cancer Overview


Ovarian cancer originates in the ovaries, fallopian tubes, or peritoneum (the lining of the abdominal wall). There are three (3) main types: Epithelial, Germ cell, and Stromal tumors. Epithelial tumors are most common, while Germ cells and Stromal tumors are rare. Like all cancers, ovarian cancer develops from genetic mutations in single cells, allowing them to reproduce uncontrollably and invade nearby tissues, eventually spreading to distant organs. For more information about the symptoms, diagnosis, and stages of ovarian cancer, please visit the University of Colorado Cancer Center's Ovarian Cancer webpage.

Despite progress made in managing ovarian cancers over the past two decades, challenges persist, such as late-stage diagnosis, high recurrence rates, treatment resistance, and poor patient survival rates. The Ovarian Cancer Innovation Group (OCIG) strives to transform ovarian cancer care by pioneering cutting-edge approaches for detection, diagnosis, prevention, and treatment. 

Our Research


Ovarian Cancer at a Glance


In 2024 approximately 19,680 new cases of ovarian cancer will be diagnosed int eh US.
The annual deth toll from ovarian cancer is estimated to be around 12,740 in 2024 in the US.
Ovarian Cancer is the 8th most common cancer in women world wide.
Recurrence rates in advanced ovarian cancer are around 25%.

 

Contact Info

Freda Ireigbe, MHA
OCIG Program Manager
13001 East 17th Place
Suite C5010
Aurora, CO 80045

Email: ocig@cuanschutz.edu
Phone: (303) 724-2435

 

 

Contact Info

Freda Ireigbe, MHA
OCIG Program Manager
13001 East 17th Place
Suite C5010
Aurora, CO 80045

Email: ocig@cuanschutz.edu
Phone: (303) 724-2435

 

CMS Login